Conclusion
The demonstration of different corticotropin-related compounds occurring in the pituitary and additionally in other body tissues, of rapid metabolic degradation processes, of the dynamic feature of the ratio between immunoassayable and bioassayable corticotropin in human plasma, and of a distinct heterogeneity of ACTH-immunoreactive material in the circulation raises a number of questions with regard to the exact dimension of ACTH-related precursor and particularly metabolic products in blood, to the secretory sources and their regulation, and to their physiological meaning. At this point, there has only been a modest beginning in looking for answers to these questions. Nevertheless, it is justified to conclude that estimates of total ACTH immunoreactivity in human plasma do not necessarily reflect activity of pituitary ACTH secretion as generally assumed and that the dynamic dichotomy of immunoactive and bioactive ACTH in plasma reflects the presence of peptide molecules which are ACTH related but devoid of steroidogenic potency. It particularly remains to be elucidated whether all these degraded molecules are simply catabolic, biologically inactive products or whether they are partially biologically active with a potential spectrum of bioactivities different from that of the native molecule. We expect this to become a most interesting and rewarding area of research in the future.
Similar content being viewed by others
References
Yalow, R.S.; Berson, S.A.: Size and charge distinctions between endogenous human plasma gastrin in peripheral blood and heptadecapeptide gastrin. Gastroenterology58: 609–615 (1970).
Rehfeld, I.J.: Heterogeneity of gastrointestinal hormones; in Glass, Gastrointestinal hormones, pp. 433–439 (Raven Press, New York 1980).
Parman, U.A.: Heterogeneity and clinical significance of circulating insulin; in Gray, James, Hormones in blood, vol.1, pp. 96–101 (Academic Press, London 1979).
Hendy, G.N.; Papapoulos, S.E.; Lewin, LG.; O’Riordan, J.L.H.: Secretion, action and metabolism of parathyroid hormone; in Gray, James, Hormones in blood, vol. 2, pp. 19–29 (Academic Press, London1979).
Yalow, R.S.; Berson, S.A.: Characteristics of ‘big ACTH’ in human plasma and pituitary extracts. J. clin. Endocr. Metab.36: 415–423 (1973).
Berson, S.A.; Yalow, R.S.: Immunochemical heterogeneity of parathyroid hormone in plasma. J. clin. Endocr. Metab.28: 1037–1047 (1968).
Yalow, R.S.; Berson, S.A.: Size heterogeneity of immunoreactive human ACTH in plasma and in extracts of pituitary glands and ACTH producing thymoma. Biochem. biophys. Res. Commun.44: 439–445 (1971).
Orth, D.N.; Nicholson, W.E.: High molecular weight forms of human ACTH are glycoproteins. J. clin. Endocr. Metab.44: 214–218 (1977).
Ratter, S.J.; Lowry, P.J.; Besser, G.M.; Rees, L.H.: Chromatographic characterization of adrenocorticotrophin in human plasma. J. Endocr.85: 359- 369 (1980).
Berson, S.A.; Yalow, R.S.: Radioimmunoassay of ACTH in plasma. J. clin. Invest.47: 2735–2751 (1968).
Hogan, P.; Rees, L.H.; Lowry, P.J.; Ratter, S.; Snitcher, E.J.: Studies on the stability of human adrenocorticotrophin in blood and plasma. J. Endocr.71: 63–64 (1976).
Meakin, J.W.; Tingey, W.H.; Nelson, D.H.: The catabolism of adrenocorticotrophic hormone: the stability of adrenocorticotrophic hormone in blood, plasma, serum and saline. Endocrinology66: 59–72(1960).
Matsuyama, H.: Studies on the inactivation of adrenocorticotrophic hormone (ACTH). I. Inactivation of ACTH in human plasma in vitro and relationship between structure and activity of ACTH. Folia endocr. jap.45: 163–172 (1969).
Imura, H.; Matsuyama, H.; Matsukura, S.; Miyake, T.; Fukase, M.: Stability of ACTH preparations in human plasma incubated in vitro. Endocrinology80: 599–602 (1967).
Richards, J.B.; Sayers, G.: Fate and excretion of adrenocorticotropic hormone. Proc. Soc. exp. Biol. Med.77: 87–93(1951).
Sydnor, K.I.; Sayers, G.: Biological half-life of endogenous ACTH. Proc. Soc. exp. Biol. Med.83: 729–733 (1953).
Rees, L.H.; RatclifTe, J.G.; Besser, G.M.; Kramer, R.; Landon, J.; Chayen, J.: Comparison of the redox assay for ACTH with previous assays. Nature new Biol.241: 84–85 (1973).
Daly, J.R.; Fleisher, M.R.; Chambers, D.J.; Bitensky, L.; Chayen, J.: Application of the cytochemical bioassay for corticotrophin to clinical and physiological studies in man. Clin. Endocr.3: 335–345(1974).
Yalow, R.S.; Glick, S.M.; Roth, J.; Berson, S.A.: Radioimmunoassay of human plasma ACTH. J. clin. Endocr. Metab.24: 1219–1225 (1964).
Besser, G.M.; Orth, D.N.; Nicholson, W.E.; Byyny, R.I.; Abe, K.; Woodham, J.P.: Dissociation of the disappearance of bioactive and radioimmunoreactive ACTH from plasma in man. J. clin. Endocr. Metab.32: 595–603 (1971).
Donald, R.A.: Radioimmunoassay of corticotrophin (ACTH); in Abraham, Handbook of radioimmunoassay, pp. 319–330 (Dekker, New York 1977).
Rees, L.H.; Lowry, P.J.: Adrenocorticotrophin and lipotrophin; in Gray, James, Hormones in blood, vol. 3, pp. 138–151 (Academic Press, London 1979).
Aronin, N.; Krieger, D.T.: Measurements of ACTH and lipotropins. Front. Horm. Res., vol. 8, pp. 62–79 (Karger, Basel 1981).
Schwyzer, R.: ACTH: a short introductory review. Ann. N.Y. Acad. Sci.297: 3–26 (1977).
Donald, R.A.: ACTH and related peptides. Clin. Endocrinol.12: 491–524 (1980).
Roberts, J.L.; Herbert, E.: Characterization of a common precursor to corticotropin and β-lipotropin: identification of β-lipotropin peptides and their arrangement relative to corticotropin in the precursor synthesized in a cell free system. Proc. natn. Acad. Sci. USA74: 5300 (1977).
Krieger, D.T.; Liotta, A.S.; Brownstein, M.J.; Zim merman, E.A.: ACTH, β-lipotrophin and related peptides in brain, pituitary and blood. Recent Prog. Horm. Res.36: 277–344 (1980).
Chrétien, M.; Seidah, N.G.: Chemistry and biosynthesis of pro-opiomelanocortin. Mol. cell. Biochem.34: 101–127 (1981).
Hope, J.; Lowry, P.J.: Pro-opiocortin: the ACTH/ LPH common precursor protein. Front. Horm. Res., vol. 8, pp. 44–61 (Karger, Basel 1981).
Eipper, B.A.; Mains, R.E.: Structure and biosynthesis of pro-ACTH/endorphin and related peptides. Endocr. Rev.1: 1–27 (1980).
Orth, D.N.; Nicholson, W.E.; Mitchell, W.M.; Island, D.P.; Liddle, G.W.: Biologic and immunologic characterization and physical separation of ACTH and ACTH fragments in the ectopic ACTH syndrome. J. clin. Invest.52: 1756–1769 (1973).
Woodford, T.A.; Dixon, J.E.: The N-acetylation of corticotropin and fragments of corticotropin by a rat pituitary N-acetyltransferase. J. biol. Chem.254: 4993–4999(1979).
Goverde, H.J.M.; Martens, G.J.M.; Smals, A.G.H.: Heterogeneity of immunoreactive and bioactive ACTH in Nelson’s syndrome and a human pituitary extract. VIIIth Dutch-British Endocrine Meeting, Noordwijkerhout. Kongress book: Abstract No. 52 (1982).
Bloch, B.; Bugnon, C.; Fellman, D.; Lenys, D.: Immunocytochemical evidence that the same neurons in the human infundibular nucleus are stained with anti-endorphins and antisera of other related peptides. Neurosci. Lett.10: 147–152 (1978).
Désy, L.; Telletier, G.: Immunohistochemical localization of alphamelanocyte-stimulating hormone (α-MSH) in the human hypothalamus. Brain Res.154: 311–381 (1978).
Pelletier, G.; Désy, L.: Localization of ACTH in the human hypothalamus. Cell Tissue Res.196: 525–530(1979).
Genazzani, A.R.; Fraioli, F.; Hurlimann, J.; Fioretti, P.; Felber, J.P.: Immunoreactive ACTH and cortisol plasma levels during pregnancy. Detection and partial purification of corticotrophin-like placental hormone. The human chorionic corticotrophin (HCC). Clin. Endocrinol.4: 1–4 (1975).
Rees, L.H.; Burke, C.W.; Chard, T.; Evans, S.W.; Letchworth, A.T.: Possible placental origin of ACTH in normal human pregnancy. Nature, Lond.254: 620–622(1975).
Larsson, L.I.: Corticotropin-like peptide in central nerves and in endocrine cells of gut and pancreas. Lancetii: 1321–1323 (1977).
Larsson, L.I.: Radioimmunochemical characterization of ACTH-like peptides in the antropyloric mucosa. Life Sci.25: 1565–1570 (1979).
Feurle, G.E.; Weber, U.; Helmstaedter, V.: Corticotropin-like substances in human gastric antrum and pancreas. Biochem. biophys. Res. Commun.95: 1656–1662 (1980).
Tanaka, I.; Nakai, Y.; Nakao, K.; Oki, S.; Masaki, N.; Ohtsuki, H.; Imura, H.: Presence of immunoreactive gamma melanocyte-stimulating hormone, adrenocorticotropin, and β-endorphin in human gastric antral mucosa. J. clin. Endocr. Metab.54: 392–396(1982).
Moldow, R.L.; Yalow, R.S.: Artifacts in the radioimmunoassay of ACTH in tissue extracts and plasma. Hormone metabol. Res.12: 105–110 (1980).
Larsson, L.I.: Immunocytochemical characterization of ACTH-like immunoreactivity in cerebral nerves and in endocrine cells of the pituitary and gastrointestinal tract by using region-specific antisera. J. Histochem. Cytochem.28: 133–141 (1980).
Bennett, H.P.J.; McMartin, C.: Peptide hormones and their analogues: distribution, clearance from the circulation and inactivation in vivo. Pharmac. Rev.30: 247–292 (1979).
Hudson, A.M.; McMartin, C.: Mechanism of catabolism of corticotrophin-(1-24)-tetracosa peptide in the rat in vivo. J. Endocr.85: 93–103 (1980).
Nicholson, W.E.; Liddle, R.A.; Puett, D.; Liddle, G.W.: Adrenocorticotrophic hormone biotransformation, clearance and catabolism. Endocrinology103: 1344–1351 (1978).
McDonald, W.J.; Golper, T.A.; Mass, R.D.; Kendall, J.W.; Porter, G.A.; Girard, D.E.; Fischer, M.D.: Adrenocorticotropin-cortisol axis abnormalities in hemodialysis patients. J. clin. Endocr. Metab.48: 92–95 (1979).
Emmanouel, D.S.; Lindheimer, M.D.; Katz, A.I.: Pathogenesis of endocrine abnormalities in uremia. Endocr. Rev.1: 28–44 (1980).
Goverde, H.J.M.: Bioactive versus immunoreactive adrenocorticotrophin in human blood; thesis Nijmegen (1981).
Fleisher, M.R.; Glass, D.; Bitensky, L.; Chayen, I.; Daly, J.R.: Plasma corticotrophin levels during insulin-induced hypoglycemia: comparison of radioimmunoassay and cytochemical bioassay. Clin. Endocr.3: 203–208 (1974).
Liotta, A.S.; Krieger, D.T.: A sensitive bioassay for the determination of human plasma ACTH levels. J. clin. Endocr. Metab.40: 268–277 (1975).
Ratter, S.J.; Hogan, P.; Lowry, P.J.; Edwards, C.R.W.; Rees, L.H.: Comparison of plasma immunoreactive and bioactive corticotrophin. J. Endocr.75: 30 (1977).
O’Hare, M.J.; Nice, E.C.: Hydrophobic high performance liquid chromatography of hormonal polypeptides and proteins on alkyl-silane bound silica. J. Chromatogr., biomed. Appl.171: 209–226 (1979).
Schöneshöfer, M.; Fenner, A.: ACTH immunoreactivities predominating in normal human plasma are not attributable to the human ACTH1–39 molecule. Biochem. biophys. Res. Commun.102: 476–483 (1981).
Seidah, N.G.; Routhier, R.; Benjannet, S.; Lariviere, N.; Gossard, F.; Chrétien, M.: Reversed phase high performance liquid chromatographic purification and characterization of the adrenocorticotropin/lipotropin precursor and its fragments. J. Chromatogr., biomed. Appl.193: 291–299 (1980).
Goverde, H.J.M.; Pesman, G.J.; Benraad, T.J.: Improved sensitivity to adrenocorticotrophin after purification and pre-incubation of isolated rat adrenal cells. Acta endocr.94: 221–228 (1980).
Schöneshöfer, M.; Schefzig, B.; Fenner, A.; Weber, B.; Dulce, H.J.: Evaluation of a sensitive radioimmunoassay of plasma corticotropin using commercial reagents. J. clin. Chem. clin. Biochem.19: 75–79 (1981).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schöneshöfer, M., Goverde, H.J.M. Corticotropin in human plasma general considerations. Surv. immunol. Res. 3, 55–63 (1984). https://doi.org/10.1007/BF02918598
Issue Date:
DOI: https://doi.org/10.1007/BF02918598